PAPER Narme P, Mouras H, Roussel M, Devendeville A, Godefroy O
SEARCH RESULTS
330026 RESULTS
PAPER Honda Y, Meguro K, Meguro M, Akanuma K
Social withdrawal of persons with vascular dementia associated with disturbance of basic daily activities, apathy, and impaired social judgment.
Care Manag J. 2013;14(2):108-13. PubMed: 23930516PAPER Eric Hwang JL, Rivas JG, Fremming R, Rivas MM, Crane KR
Relationship between perceived burden of caring for a family member with Alzheimer's disease and decreased participation in meaningful activities.
Occup Ther Health Care. 2009 Oct;23(4):249-66. PubMed: 23930923PAPER Cai Z, Hussain MD, Yan LJ
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Int J Neurosci. 2013 Sep 12; PubMed: 23930978PAPER Arora SS, Gooch JL, García PS
Postoperative Cognitive Dysfunction, Alzheimer's Disease, and Anesthesia.
Int J Neurosci. 2013 Sep 27; PubMed: 23931049PAPER Chin D, Huebbe P, Pallauf K, Rimbach G
Neuroprotective properties of curcumin in Alzheimer's disease- merits and limitations.
Curr Med Chem. 2013;20(32):3955-85. PubMed: 23931272PAPER Sheynis T, Friediger A, Xue WF, Hellewell AL, Tipping KW, Hewitt EW, Radford SE, Jelinek R
Aggregation Modulators Interfere with Membrane Interactions of β2-Microglobulin Fibrils.
Biophys J. 2013 Aug 6;105(3):745-55. PubMed: 23931322PAPER Carreiras MC, Mendes E, Perry MJ, Francisco AP, Marco-Contelles J
The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
Curr Top Med Chem. 2013;13(15):1745-70. PubMed: 23931435PAPER Rampa A, Gobbi S, Belluti F, Bisi A
Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment?
Curr Top Med Chem. 2013;13(15):1879-904. PubMed: 23931436PAPER Huang L, Su T, Li X
Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
Curr Top Med Chem. 2013;13(15):1864-78. PubMed: 23931437PAPER Caraci F, Bosco P, Leggio GM, Malaguarnera M, Drago F, Bucolo C, Salomone S
Clinical pharmacology of novel anti-Alzheimer disease modifying medications.
Curr Top Med Chem. 2013;13(15):1853-63. PubMed: 23931438PAPER Calzà L, Baldassarro VA, Giuliani A, Lorenzini L, Fernandez M, Mangano C, Sivilia S, Alessandri M, Gusciglio M, Torricella R, Giardino L
From the Multifactorial Nature of Alzheimer`s Disease to Multitarget Therapy: The Contribution of the Translational Approach.
Curr Top Med Chem. 2013;13(15):1843-52. PubMed: 23931439PAPER Martinez A, Perez DI, Gil C
Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease.
Curr Top Med Chem. 2013;13(15):1808-19. PubMed: 23931441PAPER Viayna E, Sabate R, Muñoz-Torrero D
Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates.
Curr Top Med Chem. 2013;13(15):1820-42. PubMed: 23931440PAPER Butini S, Brogi S, Novellino E, Campiani G, Ghosh AK, Brindisi M, Gemma S
The Structural Evolution of β-Secretase Inhibitors: A Focus on the Development of Small-Molecule Inhibitors.
Curr Top Med Chem. 2013;13(15):1787-807. PubMed: 23931442Current Filters
No filters selected